We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis Expects to Resume Production Under Consent Decree
Actavis Expects to Resume Production Under Consent Decree
January 13, 2009
Generic-drug maker Actavis has entered into a consent decree with the FDA that blocks the company from manufacturing drugs at its Totowa subsidiary in New Jersey, but Actavis hopes to restart production soon.